Significant proportion of cancer drugs lack proof of added benefit, finds study
MedicalXpress Breaking News-and-Events | Mar 01, 2024
Researchers find potential genetic marker linked to better survival outcomes in patients with head and neck cancer
MedicalXpress Breaking News-and-Events | Mar 01, 2024
Study proposes streamlined approach to developing cancer drugs
MedicalXpress Breaking News-and-Events | Mar 01, 2024
Bioinformatics approach offers a step toward personalised immunotherapy for all
MedicalXpress Breaking News-and-Events | Mar 01, 2024
Sensory nerves appear to drive head and neck cancer growth
MedicalXpress Breaking News-and-Events | Mar 01, 2024
New drug could unlock benefits of immunotherapy for more patients
MedicalXpress Breaking News-and-Events | Feb 29, 2024
Research identifies predictor of outcomes, chemoresistance for ovarian cancer patients
MedicalXpress Breaking News-and-Events | Feb 29, 2024
New screening tool to explore mechanisms behind cancer, autoimmunity and neurodegeneration
MedicalXpress Breaking News-and-Events | Feb 28, 2024
Predicting immunotherapy success via biomarkers
MedicalXpress Breaking News-and-Events | Feb 28, 2024
Research suggests natural compound could be promising new alternative treatment for colon cancer
MedicalXpress Breaking News-and-Events | Feb 28, 2024